Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.59 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrochalcone SCHEMBL2827303 | 1.00 | CYP19A1 (0.80) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| Dihydrochalcone SCHEMBL7540273 | 0.98 | CYP19A1 (0.77) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL1841587 | 0.89 | CYP19A1 (1.00) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL5793080 | 0.89 | CYP19A1 (0.65) | CYP19A1MAPTALDH1A1HPGDTSHR | |
| SCHEMBL30358375 | 0.86 | CYP19A1 (0.71) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL11880560 | 0.86 | ACHE (0.62) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL1733117 | 0.86 | CYP19A1 (0.71) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL10988386 | 0.86 | CYP19A1 (0.76) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| SCHEMBL3861193 | 0.86 | CYP19A1 (0.61) | CYP19A1MAPTGAASLC5A1SLC5A2 | |
| Hydrochloric Acid SCHEMBL3785617 | 0.84 | CYP19A1 (0.69) | CYP19A1MAPTGAASLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| WO-2025122010-A1 | A METHOD FOR PURIFYING A MODIFIED GELATIN | SENTRYX B.V. (NL) | 2025-06-12 | — | — | WO | claimed |
| EP-3689324-B1 | NEW COOLING AGENTS AND PREPARATIONS COMPRISING THEM | SYMRISE AG (DE) | 2024-11-20 | — | — | EP | claimed |
| EP-4418876-A1 | DIHYDROCHALCONE DERIVATIVES | Symrise AG (DE) | 2024-08-28 | — | — | EP | claimed |
| WO-2024156359-A1 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| US-20240245826-A1 | BIO-ADHESIVE | SENTRYX B.V. (NL) | 2024-07-25 | — | — | US | claimed |
| EP-3422873-B1 | LONG-LASTING SWEETENER FORMULATIONS | WRIGLEY W M JUN CO (US) | 2024-01-31 | — | — | EP | claimed |
| US-20230364172-A1 | MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY | Syncotrance, LLC | 2023-11-16 | — | — | US | claimed |
| US-20230277445-A1 | ADHESIVE DRUG CARRIER | UMC UTRECHT HOLDING B.V. (NL) | 2023-09-07 | — | — | US | claimed |
| WO-2023066890-A1 | DIHYDROCHALCONE DERIVATIVES | SYMRISE AG (DE) | 2023-04-27 | — | — | WO | claimed |
| CN-115916156-A | Improved adhesive drug carrier | UMC乌德勒支控股有限公司 | 2023-04-04 | — | — | CN | claimed |
| WO-2023002017-A1 | BIO-ADHESIVE | SENTRYX B.V. (NL) | 2023-01-26 | — | — | WO | claimed |
| US-20220298226-A1 | METHACRYLATED COLLAGEN | JELLAGEN LTD (GB) | 2022-09-22 | — | — | US | claimed |
| CN-114813900-A | Method for detecting active II type ribosome inactivating protein | 中国人民解放军军事科学院军事医学研究院 | 2022-07-29 | — | — | CN | claimed |
| EP-3442354-B1 | FORMULATION AND PRODUCTION OF SPINACH EXTRACT WITH BETA ECDYSON | DR GOETZ GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| CN-120130286-B | Method for promoting growth of lithocarpus littoralis leaves, synthesis of dihydrochalcone and reduction of heavy metal content | 广东省林业科学研究院 | 2026-05-15 | — | — | CN | disclosed |
| US-20220031602-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | L'OREAL (FR) | 2022-02-03 | — | — | US | disclosed |
| CN-114007617-A | Unit dosage form for transmucosal administration of pharmaceutically active ingredients | 葡瑞慕生物技术有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20220023302-A1 | PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE | CARDURION PHARMACEUTICALS, INC. | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023302-A1 | PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE | PDE9A, PDE2A, PDE3A | CYP19A1 3943/4885MAPT 4311/4885GAA 101/4885 |
| US-20220031602-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | CUTA, DSG1, SMURF1 | CYP19A1 386/4885MAPT 1248/4885GAA 3898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.